Upper GI Tract
Flashback
Report of potential interaction between PPIs, clopidogrel
The January 2009 issue of GI & Hepatology News (GIHN) featured an article on the potential drug interaction between proton pump inhibitors (...
From the Journals
BOS beat placebo for eosinophilic esophagitis
Budesonide oral suspension was safe and significantly outperformed placebo on validated measures of eosinophilic esophagitis, according to a first...
From the Journals
VIDEO: No difference between PPI and H2RA for low-dose aspirin gastroprotection
From the Journals
Increased death rate with platelets for aspirin/clopidogrel GI bleed
Patients with normal platelet counts who have a GI bleed while on antiplatelets were almost six times more likely to die in the hospital if they...
Conference Coverage
PPIs may boost ischemic stroke risk
NEW ORLEANS – Use of proton pump inhibitors appears to be an independent risk factor for first ischemic stroke.
Conference Coverage
Treating upper GI diseases: Where do we go from here?
WASHINGTON – A first-of-its-kind meeting of the AGA, FDA, and other stakeholders brings about discussion of emerging treatments, therapies, and...
From the Journals
POEM procedure effective over the long term in achalasia
The therapeutic endoscopic procedure per-oral endoscopic myotomy (POEM) is safe and has a high clinical success rate at 2 years in patients with...
Feature
AGA Clinical Practice Update: Refer early Barrett’s dysplasia to a specialist
Low-grade esophageal dysplasia must be confirmed by a GI pathologist with a special interest in Barrett’s esophagus, one who deals with the...
From the Journals
Oral bacterium linked to poor esophageal cancer survival
Fusobacterium nucleatum
From the Journals
Tryptase gene variant linked to GI, joint, and skin symptoms
Researchers have identified a genetic variant associated with inherited elevated basal serum tryptase levels and linked to a distinct group of...